Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TransUnionTRU · Entity 2287 | EVP - Healthcare | July 30, 2018 | August 01, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TransUnion
Report date July 30, 2018 · Filed August 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 99,390 |
Reported balance
After 2018-07-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-07-30 · Exercise / conversion · Acquired 62,752 · Balance 99,390 |
| Common StockSEC Table I · non-derivative | Direct | 37,049 |
Reported balance
After 2018-07-30 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-07-30 · Sale · Disposed 62,752 · Balance 37,049 F1: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.38 to $70.77, inclusive. The reporting person undertakes to provide to TransUnion, any security holder of TransUnion, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes 411 shares of common stock acquired pursuant to the issuer's employee stock purchase plan since the reporting person's last report. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.06 · Expires 2024-07-01 | Direct | 62,085 |
Reported balance
After 2018-07-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-07-30 · Exercise / conversion · Disposed 62,752 · Balance 62,085 F3: Represents an initial grant of 248,337 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017. The time-based vesting criteria is satisfied as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.38 to $70.77, inclusive. The reporting person undertakes to provide to TransUnion, any security holder of TransUnion, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: Includes 411 shares of common stock acquired pursuant to the issuer's employee stock purchase plan since the reporting person's last report.
F3: Represents an initial grant of 248,337 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017. The time-based vesting criteria is satisfied as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 30, 2018 Filed Aug 1, 2018 22:28 UTC | TransUnion TRU · Entity 2287 | Exercise / conversionStock Options (right to buy) · Derivative | 62,752 | $13.06 Strike: $13.06 | $819,541.12 |
DisclosureSEC source: 0001645766-18-000008 · wf-form4_153316250155714.xml · derivative · entry 3 McCarthy Gerald M JR · CIK 0001645766 · EVP - Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,085 Underlying: Common Stock · 62,752 shares Expires 2024-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents an initial grant of 248,337 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017. The time-based vesting criteria is satisfied as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 22:28 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 62,752 | $70.61 | $4,430,918.72 |
DisclosureSEC source: 0001645766-18-000008 · wf-form4_153316250155714.xml · nonDerivative · entry 2 McCarthy Gerald M JR · CIK 0001645766 · EVP - Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,049 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.38 to $70.77, inclusive. The reporting person undertakes to provide to TransUnion, any security holder of TransUnion, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 411 shares of common stock acquired pursuant to the issuer's employee stock purchase plan since the reporting person's last report. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 22:28 UTC | TransUnion TRU · Entity 2287 | Exercise / conversionCommon Stock | 62,752 | $13.06 | $819,541.12 |
DisclosureSEC source: 0001645766-18-000008 · wf-form4_153316250155714.xml · nonDerivative · entry 1 McCarthy Gerald M JR · CIK 0001645766 · EVP - Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 22:21 UTC | TransUnion TRU · Entity 2287 | Exercise / conversionStock Options (right to buy) · Derivative | 50,000 | $4.99 Strike: $13.06 | $249,500.00 |
DisclosureSEC source: 0001645766-18-000006 · wf-form4_152875567338498.xml · derivative · entry 3 McCarthy Gerald M JR · CIK 0001645766 · EVP - Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,837 Underlying: Common Stock · 50,000 shares Expires 2024-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents an initial grant of 248,337 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017. The time-based vesting criteria is satisfied as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 22:21 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 50,000 | $70.84 | $3,542,000.00 |
DisclosureSEC source: 0001645766-18-000006 · wf-form4_152875567338498.xml · nonDerivative · entry 2 McCarthy Gerald M JR · CIK 0001645766 · EVP - Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,638 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.50 to $71.39, inclusive. The reporting person undertakes to provide to TransUnion, any security holder of TransUnion, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 22:21 UTC | TransUnion TRU · Entity 2287 | Exercise / conversionCommon Stock | 50,000 | $13.06 | $653,000.00 |
DisclosureSEC source: 0001645766-18-000006 · wf-form4_152875567338498.xml · nonDerivative · entry 1 McCarthy Gerald M JR · CIK 0001645766 · EVP - Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 23:42 UTC | TransUnion TRU · Entity 2287 | GrantCommon Stock | 6,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001645766-18-000004 · wf-form4_151917012141628.xml · nonDerivative · entry 1 McCarthy Gerald M JR · CIK 0001645766 · EVP - Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,638 F1 · kind: Represents a grant of restricted stock units that vest on the third anniversary of the date of grant. F2 · balance_after: Includes 734 shares of common stock acquired pursuant to the issuer's employee stock purchase plan since the reporting person's last report. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:38 UTC | TransUnion TRU · Entity 2287 | Exercise / conversionStock Options (right to buy) · Derivative | 73,500 | $13.06 Strike: $13.06 | $959,910.00 |
DisclosureSEC source: 0001645766-17-000006 · wf-form4_149505347418628.xml · derivative · entry 3 McCarthy Gerald M JR · CIK 0001645766 · EVP - Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,837 Underlying: Common Stock · 73,500 shares Expires 2024-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents an initial grant of 248,337 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017. The time-based vesting criteria is satisfied as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:38 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 73,500 | $41.68 | $3,063,480.00 |
DisclosureSEC source: 0001645766-17-000006 · wf-form4_149505347418628.xml · nonDerivative · entry 2 McCarthy Gerald M JR · CIK 0001645766 · EVP - Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,061 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.52 to $41.76, inclusive. The reporting person undertakes to provide to TransUnion, any security holder of TransUnion, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:38 UTC | TransUnion TRU · Entity 2287 | Exercise / conversionCommon Stock | 73,500 | $13.06 | $959,910.00 |
DisclosureSEC source: 0001645766-17-000006 · wf-form4_149505347418628.xml · nonDerivative · entry 1 McCarthy Gerald M JR · CIK 0001645766 · EVP - Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 22:33 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 11,000 | $36.57 | $402,270.00 |
DisclosureSEC source: 0001645766-17-000004 · wf-form4_148788919229788.xml · nonDerivative · entry 1 McCarthy Gerald M JR · CIK 0001645766 · EVP - Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,061 Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 23:34 UTC | TransUnion TRU · Entity 2287 | GrantCommon Stock | 9,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001645766-17-000002 · wf-form4_148780644032882.xml · nonDerivative · entry 1 McCarthy Gerald M JR · CIK 0001645766 · EVP - Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,061 F1 · kind: Represents a grant of restricted stock units that vest on the third anniversary of the date of grant. F2 · balance_after: Includes 314 shares of common stock acquired pursuant to the issuer's employee stock purchase plan since the reporting person's last report. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.